Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Overview

Journal Ann Intern Med

Specialty General Medicine

Date 2008 Aug 6

PMID 18678845

Citations 207

Affiliations

Soon will be listed here.

Abstract

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer.

Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation.

Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

Citing Articles

Trends in age and prostate-specific antigen at prostate cancer diagnosis between 2010 and 2019.

Owens L, Brahme O, Gulati R, Etzioni R JNCI Cancer Spectr. 2024; 8(6).

PMID: 39441819 PMC: 11578289. DOI: 10.1093/jncics/pkae106.

The Short- and Long-Term Anticipation of Prostate Cancer Incidence in Korea: Based on Social Aging Trends and Prostate-Specific Antigen Testing Rate during the Last Decade.

Pyun J, Ko Y, Kim S, Son N Cancers (Basel). 2024; 16(3).

PMID: 38339255 PMC: 10854490. DOI: 10.3390/cancers16030503.

A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer.

Wu H, Wu Y, He P, Liang J, Xu X, Ji C PLoS One. 2024; 19(2):e0285745.

PMID: 38329970 PMC: 10852267. DOI: 10.1371/journal.pone.0285745.

Trends in prostate cancer incidence among Black men in the Caribbean and the United States.

Zeigler-Johnson C, McDonald A, Pinheiro P, Lynch S, Taioli E, Joshi S Prostate. 2023; 83(12):1207-1216.

PMID: 37244749 PMC: 11256998. DOI: 10.1002/pros.24580.

Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.

Rao Bommi J, Kummari S, Lakavath K, Sukumaran R, Panicker L, Marty J Biosensors (Basel). 2023; 13(3).

PMID: 36979610 PMC: 10046866. DOI: 10.3390/bios13030398.